{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:53:52Z","timestamp":1793843632686,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US Defense Health Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vaccine.2012.12.029","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T11:32:15Z","timestamp":1357212735000},"page":"1623-1632","source":"Crossref","is-referenced-by-count":77,"title":["History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system"],"prefix":"10.1016","volume":"31","author":[{"suffix":"Jr.","given":"Charles H.","family":"Hoke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Clifford E.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April (Suppl. 4)","key":"10.1016\/j.vaccine.2012.12.029_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7205\/MILMED.170.4S.3","article-title":"History of U.S. military contributions to the study of vaccines against infectious diseases","volume":"170","author":"Artenstein","year":"2005","journal-title":"Mil Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.12.029_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2105\/AJPH.48.2.153","article-title":"Efficacy of and indications for use of adenovirus vaccine","volume":"48","author":"Hilleman","year":"1958","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0015","series-title":"Protecting our forces: improving vaccine acquisition and availability in the U. S. Military","first-page":"108","article-title":"Urgent attention needed to restore lapsed Adenovirus Vaccine availability. A letter report","author":"Lemon","year":"2002"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0020","unstructured":"AFEB Recommendations on adenovirus vaccine: http:\/\/www.health.mil\/dhb\/1998\/1998-04.pdf [accessed 26.06.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0025","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.vaccine.2005.12.062","article-title":"Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999\u20132004","volume":"24","author":"Russell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0030","unstructured":"Department of Defense Directive 5000.01. http:\/\/www.dtic.mil\/whs\/directives\/corres\/pdf\/500001p.pdf [site accessed 05.07.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0035","unstructured":"Capability Production Document. https:\/\/acc.dau.mil\/ILC_CPD [accessed 05.07.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/313999","article-title":"Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group","volume":"31","author":"Gray","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0045","unstructured":"Rules of the Road: a guide for leading successful integrated product teams. https:\/\/acc.dau.mil\/CommunityBrowser.aspx?id=106006 [accessed 26.06.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0055","unstructured":"Barr dedicates adenovirus production facility. http:\/\/www2.prnewswire.com\/cgi-bin\/stories.pl?ACCT=104&STORY=\/www\/story\/07-03-2003\/0001976361&EDATE=July 3, 2003 [accessed 05.07.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0060","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1128\/JCM.32.9.2331-2334.1994","article-title":"Quantitative colorimetric microneutralization assay for characterization of adenoviruses","volume":"32","author":"Crawford-Miksza","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.12.029_bib0065","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/JCM.43.11.5743-5752.2005","article-title":"PCR analysis of Egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections","volume":"43","author":"Metzgar","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0070","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/JCM.00029-10","article-title":"Multiplexed Luminex xMAP assay for detection and identification of five adenovirus serotypes associated with epidemics of respiratory disease in adults","volume":"48","author":"Washington","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0075","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/522970","article-title":"Abrupt emergence of diverse species B adenoviruses at US military recruit training centers","volume":"196","author":"Metzgar","year":"2007","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2012.12.029_bib0080","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 Adenovirus Vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0085","unstructured":"Package insert: adenovirus type 4 and type 7 vaccine, live, oral. http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM247515.pdf [accessed 05.07.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0090","unstructured":"March 16, 2011 approval letter adenovirus type 4 and type 7, live, oral. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/approvedProducts\/ucm247511.htm [accessed 05.07.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0095","unstructured":"Integrated Logistics Support Plan: https:\/\/acc.dau.mil\/CommunityBrowser.aspx?id=280255 [accessed 05.07.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0110","first-page":"2","article-title":"Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees","volume":"19","author":"Hoke","year":"2012","journal-title":"MSMR"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0115","unstructured":"Total Life Cycle Systems Management: https:\/\/acc.dau.mil\/CommunityBrowser.aspx?id=325272 [accessed 17.08.12]."},{"key":"10.1016\/j.vaccine.2012.12.029_bib0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/milmed\/160.6.300","article-title":"Adenovirus vaccines in the U.S. military","volume":"160","author":"Gaydos","year":"1995","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0125","first-page":"185","article-title":"The Jeremiah Metzger Lecture. Vaccine prophylaxis today: its science, application and politics","volume":"109","author":"Douglas","year":"1998","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0130","doi-asserted-by":"crossref","first-page":"e7081","DOI":"10.1371\/journal.pone.0007081","article-title":"Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples","volume":"4","author":"Metzgar","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0135","first-page":"1181","article-title":"Acute respiratory disease associated with adenovirus serotype 14\u2013four states, 2006\u20132007","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0140","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/522969","article-title":"Emergence of adenovirus 14 in US military recruits\u2013a new challenge","volume":"196","author":"Binn","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0145","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.1961.03040510001001","article-title":"Effects of adenovirus vaccine on acute respiratory disease in U.S. Army recruits","volume":"178","author":"Sherwood","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/oxfordjournals.aje.a121306","article-title":"Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines","volume":"94","author":"Top","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7","volume":"124","author":"Top","year":"1971","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/oxfordjournals.aje.a121378","article-title":"An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines","volume":"95","author":"Dudding","year":"1972","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/00039896.1972.10666192","article-title":"Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types","volume":"25","author":"Gooch","year":"1972","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0170","first-page":"185","article-title":"Control of adenovirus acute respiratory disease in U.S. Army trainees","volume":"48","author":"Top","year":"1975","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/148.5.775","article-title":"Viral respiratory disease at Lowry Air Force Base in Denver, 1952\u20131982","volume":"148","author":"Meiklejohn","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.029_bib0180","unstructured":"Poland Gregory et al. (Eds.), Recommendation 4 in \u201cVaccines in the military: A Department of Defense-Wide Review of Vaccine Policy and Practice\u201d, Found at http:\/\/health.mil\/dhb\/vaccines.pdf [accessed 20.08.12], 1999, p. 10."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12017999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12017999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T15:09:04Z","timestamp":1595171344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12017999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0264410X12017999"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}